1. Home
  2. DTIL vs REA Comparison

DTIL vs REA Comparison

Compare DTIL & REA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

HOLD

Current Price

$7.29

Market Cap

214.7M

Sector

Health Care

ML Signal

HOLD

Logo Rare Earths Americas Inc. Common Stock

REA

Rare Earths Americas Inc. Common Stock

N/A

Current Price

$10.57

Market Cap

232.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
DTIL
REA
Founded
2006
N/A
Country
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Mining
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
214.7M
232.3M
IPO Year
2019
2026

Fundamental Metrics

Financial Performance
Metric
DTIL
REA
Price
$7.29
$10.57
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$45.00
N/A
AVG Volume (30 Days)
632.2K
120.8K
Earning Date
05-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,070,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.53
$10.59
52 Week High
$9.62
$17.84

Technical Indicators

Market Signals
Indicator
DTIL
REA
Relative Strength Index (RSI) 44.11 29.59
Support Level $6.30 N/A
Resistance Level $7.96 $12.20
Average True Range (ATR) 0.62 1.05
MACD -0.19 -0.03
Stochastic Oscillator 11.37 3.48

Price Performance

Historical Comparison
DTIL
REA

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

About REA Rare Earths Americas Inc. Common Stock

Rare Earths Americas Inc is an exploration stage company focused on advancing projects related to rare earth minerals. Its activities include evaluating mineralization and assessing the characteristics and economic potential of its assets. Its portfolio includes the Shiloh Project in Georgia, United States; the Alpha Project in Bahia, Brazil; and the Constellation Project in Minas Gerais, Brazil. It also holds additional early-stage exploration projects, including the Homer Project in Goiás, Brazil, and the Liberty Peak Project in Georgia, United States. The company has two reportable segments due to their geographical location: United States Mining Operations and Brazil Mining Operations.

Share on Social Networks: